Emyria teams with CRO PsychoGenics for MDMA-like drug development
By Joseph Keenan · Sep 21, 2022 · Fierce Biotech Australian biotech Emyria and U.S.-based CRO PsychoGenics have agreed to a collaborate on...
Overcoming mental health’s drug development challenges with AI
By Kelly Bilodeau · Aug. 23, 2022 · PharmaVoice PsychoGenics is leveraging AI-driven drug discovery platforms to advance mental health treatments...
PsychoGenics – Phenotypic Drug Discovery and Preclinical CRO
Aug. 22, 2022 · Health Professional Radio Mark Varney, Ph.D., Chief Scientific Officer of PsychoGenics, an AI-enabled phenotypic drug discovery and preclinical...
Industrializing behavioral testing to redefine neuropsychiatric drug discovery
PsychoGenics uses a high-throughput platform comprising cameras and AI to analyze the behaviors of mice given a drug candidate before...
We need a new Prozac: The demand for brain drug innovation
[et_pb_section fb_built=”1″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][/et_pb_post_title][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]...
Mental Health Champions: Why & How Dr. Emer Leahy of PsychoGenics Is Helping To Champion Mental Wellness
By Yitzi Weiner · Aug. 14, 2022 · Medium Delegate and accept imperfection — I find myself getting anxious when...
The CNS drug development drum beat is getting louder
By Brian Buntz | August 1, 2022 [image courtesy of Pixabay] The late 1980s and the 1990s were something of a gold rush...
PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities
Biopharmaceutical Industry Veterans David Bleakman and Thomas Oakley Each Bring Three Decades of Experience to the Company Paramus, N.J., June...
GBR Connect Series – Interview with Emer Leahy, PsychoGenics
Can you give an overview of how business has evolved for PsychoGenics over the past year? There are two sides...
PsychoGenics’ High Data Security Standards Are Certified by The NIH
PsychoGenics Inc. (PGI), a provider of AI-based phenotypic platforms and preclinical assays for the development of therapeutics for pain, neurodegenerative,...